Last reviewed · How we verify
Allergic urticaria
Approved treatments
- Clarinex · Generic (originally Schering-Plough/MSD)
Active metabolite of loratadine with higher potency at H1 receptors and additional anti-inflammatory properties. - Desloratadin · Max Zeller Soehne AG
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Allergic urticaria patent landscape — cliff calendar, originator estates, attackable patents
- Allergic urticaria treatment landscape brief
- Allergic urticaria treatment updates RSS
Frequently asked questions about Allergic urticaria
What drugs treat Allergic urticaria?
Tracked treatments include Clarinex, Desloratadin.
What is the treatment for Allergic urticaria?
Standard treatment for Allergic urticaria includes Clarinex, Desloratadin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Allergic urticaria patent cliff · Allergic urticaria CI report
- Treatment: Clarinex · Generic (originally Schering-Plough/MSD)
- Treatment: Desloratadin · Max Zeller Soehne AG
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing